TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Physical Anhedonia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in femur length at 36 weeks' gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incremental economic implementation costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hippocampal-dependent topographical memory task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Suppression of bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Objective cure (POP‐Q Ba ≤ ‐ 2 and Ba ≤ ‐ 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective cure (VSS, no vaginal symptom)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life impact due to subjective vaginal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall efficacy perception score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment tolerability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: odds of hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: emergency department admissions
Endpoint domain: Mortality/survival
Primary endpoint: total spending
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Response to therapy at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in seizure count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Improvement in MMSE score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Achieving hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased hemorrhagic death
Endpoint domain: Mortality/survival
Primary endpoint: Years of life expectancy gained
Endpoint domain: Mortality/survival
Primary endpoint: Increase in blood SMN protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement or stabilization in motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in verbal learning and memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting-state ReHo in right orbitofrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean RLN identification time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Completion of cancer treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total FLS times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor neurological outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: height growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intelligence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary continence scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower urinary tract symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual function subscale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of uterine incision extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency of acromioplasty within 2 years
Endpoint domain: Mortality/survival
Primary endpoint: perioperative red blood cell transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: total bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: connectivity to the left angular gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean adenoma number per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: positioning accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angle accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PC/PE ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SM/Cer ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite differences in pyrimidine and purine pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolite differences in tyrosine and galactose pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA and protein expression of IL‐6, IL‐8 and IL‐1β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OSDI correlation with IC/IL‐1β, IC/IL‐10 and tear/IL‐1β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Satisfaction with the study drug
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to recommend the method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to pay for the study drug
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: remission of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coefficient of repeatability (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriateness of prescriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective nebuliser adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score during pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30% improvement on ODI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (QoL) deterioration
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity for confirmed OHCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for confirmed OHCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value for confirmed OHCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PTDM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall biopsy-proven rejections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: freedom from acute rejection, graft loss, and death
Endpoint domain: Mortality/survival
Primary endpoint: Classification accuracy for grade 1 versus grade 3 ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Out-of-home care (OOHC) rate
Endpoint domain: Mortality/survival
Primary endpoint: Reunification rate
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of SPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in muscle stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean daily SSB consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean daily percentage of energy from SSBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapeutic effects measured by behavioral, neuroimaging, and electrophysiologic endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient preparedness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: tic severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective xerostomia scores (SXI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary flow (UWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitamin D3 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: average gap measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum load-to-failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4+ concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endurance improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower body strength improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of diagnosis and recording of decayed teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Skin sensitivity to sodium lauryl sulfate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: neurological recovery
Endpoint domain: Mortality/survival
Primary endpoint: one-year PFS rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative complication rate of C-D grade 3 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bile leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Structural modification of cartilage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Energy expenditure (kcal/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in fidelity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BCVA letter improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: twitch contractile properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: perioperative ischemic cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sensorimotor function performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tiredness reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: lesion response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of incident heart failure (HF)
Endpoint domain: Mortality/survival
Primary endpoint: Treatment effectiveness for PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment IMSmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-intervention stability scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: anatomical understanding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean endotracheal intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visualization of glottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax and AUC of ASP3652
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: usability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to perform measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of LGA births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of SGA births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of LBW
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Ability to have sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CMCT related to APB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Meeting sexual partners online
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Condomless sex with temporary partner
Endpoint domain: Adverse events/effects
Primary endpoint: Testing for sexually transmitted infections (STIs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Emotional impacts of using a wearable
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Appreciation of personalized sympathy cards
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in O’Leary‐Sant Interstitial Cystitis Symptom Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Facilitation of informed cervical cancer screening decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to scripted lesson plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in methylation levels at CpG sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in carotid artery intima‐media thickness (CIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annual Failure Rate (AFR) after 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global improvement overall
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attainment of 2 or more primary targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCTQ-severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BCTQ-function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CBF indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective burden of disease (MSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: muscle activity in lower trapezius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle activity in serratus anterior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scapular upward rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scapular posterior tilting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy concerning advance care planning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Remission of comorbid depressive symptoms after two years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of readmission for jaundice
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of severe hyperbilirubinaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in subjective and objective measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of falling risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgeon volume meeting annual thresholds for CEA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of motor block
Endpoint domain: Adverse events/effects
Primary endpoint: acute alcohol craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death from any cause or hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Complication free survival
Endpoint domain: Mortality/survival
Primary endpoint: reduction of viable bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 1-year incisional hernia development
Endpoint domain: Adverse events/effects
Primary endpoint: sore throat frequency
Endpoint domain: Adverse events/effects
Primary endpoint: DASH Health Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment failure on day 21
Endpoint domain: Mortality/survival
Primary endpoint: Pazopanib-related deaths
Endpoint domain: Adverse events/effects
Primary endpoint: 3 and 5-year survival prediction
Endpoint domain: Mortality/survival
Primary endpoint: Ability to swallow capsules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with dosing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Affective response to exercise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in VO₂max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EBL as a percentage of TBV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: theory test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skill assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MASA-OC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perpetrating physical ARA
Endpoint domain: Adverse events/effects
Primary endpoint: Parent anxiety scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: High-risk prescribing improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Women's acceptance of STan+CTG monitoring
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Responsiveness to zinc supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 6-minute walk test distance (6MWTD) change to Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in collarette grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk and intensity of TS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of machine learning in identifying OSCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meaningfulness of activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular death alone
Endpoint domain: Mortality/survival
Primary endpoint: abdominal pain after 12 h
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Knowledge score of mothers on CHX gel
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: faster walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in treatment at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrival to next-day appointments for continued medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight gain as measured by BMI percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exposure to hyperoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rabies Neutralizing Antibody (RNVA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean error rate in identification of Or
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the Liaison antigen test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the Liaison antigen test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-promoting behaviors
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Need for medical interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of CHEOPS scores > 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMD incidence
Endpoint domain: Mortality/survival
Primary endpoint: AMD progression
Endpoint domain: Mortality/survival
Primary endpoint: Antimicrobial efficacy against S. mutans and E. coli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Fracture load of PMMA denture base
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes